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Altered Bone Morphogenetic Protein (BMP) signaling leads to multiple developmental defects, including brachydactyly and deafness.
Here we identify chondroitin synthase 1 (CHSY1) as a potential mediator of BMP effects. We show that loss of human CHSY1 function
causes autosomal-recessive Temtamy preaxial brachydactyly syndrome (TPBS), mainly characterized by limb malformations, short
stature, and hearing loss. After mapping the TPBS locus to chromosome 15q26-qterm, we identified causative mutations in five consan-
guineous TPBS families. In zebrafish, antisense-mediated chsy1 knockdown causes defects in multiple developmental processes, some of
which are likely to also be causative in the etiology of TPBS. In the inner ears of zebrafish larvae, chsy1 is expressed similarly to the BMP
inhibitor dan and in a complementary fashion to bmp2b. Furthermore, unrestricted Bmp2b signaling or loss of Dan activity leads to
reduced chsy1 expression and, during epithelial morphogenesis, defects similar to those that occur upon Chsy1 inactivation, indicating
that Bmp signaling affects inner-ear development by repressing chsy1. In addition, we obtained strikingly similar zebrafish phenotypes
after chsy1 overexpression, which might explain why, in humans, brachydactyly can be caused by mutations leading either to loss or to
gain of BMP signaling.Introduction
Brachydactylies are characterized by finger and toe short-
ening caused by short or absent metacarpus or metatarsus
and/or phalanges. They can occur either as an isolated trait
or as part of a syndrome in combination with other devel-
opmental malformations. Recent analyses have identified
mutations in components of the Bone Morphogenetic
Protein (BMP) signaling pathway or its modulators as the
cause of different types of brachydactyly. According to
current concepts, loss of BMP signaling, as for example
caused by loss-of-function mutations in the BMP ligand
GDF5 (MIM 601146) or the GDF5 high-affinity receptor
BMPR1B (MIM 603248), leads to reduced bone formation
and brachydactyly type A2 (BDA2 [MIM 112600]) or type
C (BDAC [MIM 113100]),1 whereas gain of BMP signaling,
as manifested by loss-of-function mutations in the BMP
inhibitor Noggin (MIM 602991), can result in compro-
mised joint formation between the different bony hand
and foot elements and in the development of symphalan-
gism (SYM1 [MIM 185800]) and/or multiple synostosis
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The Americanof BMP signaling seem to be more complex and subject
to intensive fine tuning. For instance, in addition to being
caused by loss of GDF5 activity, BDA2 can also be caused by
gain of BMP2 signaling, and brachydactyly type B2 (BDB2
[MIM 611377]) can be caused by missense mutations
in Noggin (Mundlos1 and references therein). Similarly,
both GDF5 and Noggin mutations are linked to deafness
in SYNS1.3 In light of this, the exact roles of BMP signaling
and the nature of mediators accounting for the differential
effects remain largely obscure.
The Temtamy preaxial brachydactyly syndrome (TPBS
[MIM 605282]) is an autosomal-recessive congenital syn-
drome mainly characterized by bilateral, symmetric pre-
axial brachydactyly and hyperphalangism of digits, facial
dysmorphism, dental anomalies, sensorineural hearing
loss, delayed motor and mental development, and growth
retardation.4
Here we mapped the TPBS locus to chromosome 15q26-
qterm and identified causative mutations in CHSY1 (MIM
608183) in five TPBS families. The zebrafish has recently
emerged as a suitable animal model for human develop-
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loss and gain of chsy1 function lead to defects similar to
those in human TPBS patients. Such defects include
reduced body length, compromised formation of the
pectoral fin, severe midline deficiencies in the cartilage of
the neurocranium, and compromised formation of epithe-
lial protrusions and semicircular canals in the inner ear.
Moreover, we demonstrate that Bmp signaling has a nega-
tive effect on chsy1 expression and that Dan is required for
inhibition of Bmp signaling and derepression of chsy1
expression in epithelial protrusions, and it thereby allows
semicircular canal morphogenesis.Material and Methods
Subjects
All subjects or their legal representatives gave written informed
consent to the study. The study was performed in accordance to
the Declaration of Helsinki protocols and approved by the local
institutional review boards. Five families with the clinical diag-
nosis of Temtamy preaxial brachydactyly (TPBS) were included
in the study. Clinical features of some of the families have been
already published: TPB1,4 TPB4,6 and TPB5.7 Patients underwent
general otological examinations and pure-tone audiometry with
air and bone conduction at 250 Hz, 500 Hz, 1000 Hz, 2000 Hz,
4000 Hz, and 8000 Hz. Vestibular evaluation in affected individ-
uals did not reveal any symptoms of vestibular dysfunction.
Moderate to profound sensorineural hearing impairment was
diagnosed in families TPB1 (individual II-2), TPB2 (individual
II-2), TPB3 (individuals II-3 and II-5), TPB4 (individual II-2), and
TPB5 (individuals II-5 and II-6). DNA from participating family
members was extracted from peripheral blood lymphocytes by
standard extraction procedures.
Linkage Analysis
Genome-wide linkage analysis in available members of the TB1
and TB2 families was performed with the Affymetrix GeneChip
Human Mapping 10K SNP Array Xba142 (version 2.0). Genotypes
were called by the GeneChip DNA Analysis Software (GDAS v3.0,
Affymetrix). We verified sample genders by counting heterozy-
gous SNPs on the X chromosome. Relationship errors were
evaluated with the help of the program Graphical Relationship
Representation.8 The program PedCheck detected Mendelian
errors,9 and data for SNPs with such errors were removed from
the data set. Non-Mendelian errors were identified with the
program MERLIN,10 and unlikely genotypes for related samples
were deleted. Linkage analysis was performed under the assump-
tion of autosomal-recessive inheritance, full penetrance, consan-
guinity, and a disease gene frequency of 0.0001. Multipoint
LOD scores were calculated with the program ALLEGRO.11 Haplo-
types were reconstructed with ALLEGRO and presented graphi-
cally with HaploPainter.12 All data handling was performed
with the graphical user interface ALOHOMORA.13 For the TPB3
family, an independent genome-wide 250K NspI Affymetrix
SNP Array (Affymetrix, CA, USA) analysis was done on all mem-
bers of the nuclear family at the Genome Sciences Laboratory
of the Ankara University Biotechnology Institute. SNP Array
data were analyzed by Genespring GT (Agilent, Santa Clara, CA,
USA). For subsequent fine mapping, known and newly designed
microsatellite markers for the critical region were genotyped
(Table S2).758 The American Journal of Human Genetics 87, 757–767, DecembMutation Screening
We searched databases to identify candidate genes in the critical
region on chromosome 15q26-qterm (GeneDistiller, Ensemble
Genome Server, and UCSC Genome Bioinformatics). Four candi-
date genes, ADAMTS17 (MIM 607511), CHSY1, SELS (MIM
607918), and PCSK6 (MIM 167405), were chosen for mutation
screening on the basis of their expression pattern and presumed
functional properties (OMIM and Unigene). Primers were
designed according to the reference sequences. The coding exons
and adjacent splice sites of these candidate genes were sequenced
in the index patients of TPB1 and TPB2 families. We amplified
the three exons of CHSY1 (CHSY1, NC_000015.9; CHSY1,
NP_055733.2; Table S2) from DNA of all affected members of the
five families and sequenced the PCR products by BigDye Termi-
nator method on an ABI 3100 sequencer. We resequenced all
identified mutations in independent experiments and tested for
cosegregation within the families. We tested 150 healthy control
individuals from Turkey, 30 from Morocco, and 30 from Egypt
for the mutations in exon 1 (c.55-84del30, c.14delG, and
c.205C>T) by direct sequencing. One hundred twenty controls
from Pakistan and 40 from Turkey were tested for the mutation
of c.3213C>G by PCR and restriction digestion, and 150 con-
trols from Pakistan were tested for the p.P539R mutation. CHSY
protein sequence was analyzed with the server Pfam for protein
domains. All primer sequences of designed polymorphic markers
on 15qter and primer sequences for genomic and cDNA amplifica-
tion of CHSY1 can be found in Table S2.
CHSY1 cDNA Analysis
RNA was extracted from fresh blood with the Paxgene Blood RNA
system (QIAGEN). Reverse-transcriptase polymerase chain reac-
tion (RT-PCR) was performed with RevertAid First Strand cDNA
synthesis Kit (Fermentas). The primers for amplification were
designed according to the reference sequence and located in
exon 1 and exon 3 (CHSY1 mRNA, NM_014918.4; Table S2).
Histology
Whole-mount in situ hybridizations, immunostainings, and dou-
ble in situ hybridizations were carried out as described.14,15 For
chsy1 probe synthesis, a 1030 bp fragment of zebrafish chsy1
cDNA (GenBank accession number BC06467016) was amplified
via RT-PCR, cloned into pCRII (Invitrogene), linearized with Hin-
dIII, and transcribed with T7 RNA polymerase. Sense control probe
was generated with NotI and SP6 RNA polymerase. The bmp2b,
msxc, and sox9a probes were generated as described.17–19 Fluores-
cein-phalloidin staining of hair cells in sensory patches of inner
ears was carried out as described.17
Morpholino Injection
Two sequence-independent antisense morpholino oligonucleo-
tides (MOs) targeting the translational start codon (chsy1-ATG
MO) or 50 untranslated region (chsy1-UTR MO) were purchased
from GeneTools. Sequences were as follows: chsy1-ATG MO,
50-AAGATCTGCGACTCCTTCCTGCCAT-30 (identical to MO in
Zhang et al.16 and Peal et al.20); and chsy1-UTR MO, 50-CTAG
TCGCTTTAATTTGTCAGAGTT-30. MOs were injected into 1- to
4-cell-stage embryos, as described;21 per embryo, 1.5 nl was in-
jected at concentrations ranging from 66–333 mM (ATG MO)
and from 333–500 mM (UTR MO). To avoid unspecific toxicity,
we coinjected the UTR MO with p53-MO.22 To control knock-
down efficacy, we cloned the 50 UTR and the first 46 nucleotideser 10, 2010
Figure 1. Clinical and Molecular Findings in Families with TPBS
(A) A haplotype analysis of the 15q26-qterm critical region indicates homozygosity in affected individuals of the TPB1, TPB2, and TPB3
families.
(B) Typical hand anomalies and skeletal findings seen in our patients with TPBS.
(C) Genomic overview of the 15q26 critical region and genomic localization of the genes tested.
(D) Electropherograms of identified homozygous CHSY1 mutations compared to wild-type sequences. Above, wild-type sequences are
shown.
(E) Schematic view of CHSY1 protein domains, coding exons, and localization of identified CHSY1 mutations.of the coding region into pCS2þ vector23 and fused it to GFP.
The plasmid was linearized with NotI, and chsy1-gfp hybrid
mRNA was generated with the SP6 MessageMachine Kit (Am-
bion, Austin, TX). Injection of this mRNA into zebrafish embryos
yielded strong GFP fluorescence at late gastrula stages (Figure S3).
However, fluorescence was completely suppressed upon subse-
quent coinjection of the mRNA with chsy1-ATG MO or chsy1-
UTR MO (Figure S3). dan MO injections were done as
described.24Overexpression Studies
For chsy1 overexpression, the coding region of human CHSY1 was
cloned into the Cla1 and XhoI sites of pCS2þ.23 The plasmid was
linearized with NotI, and capped sense RNA was synthesized
in vitro via the SP6 MessageMachine Kit (Ambion, Austin, TX).
mRNA (1.5 nl) was injected into 1- to 4-cell-stage embryos at
a concentration of 100 ng/ml. For temporally controlled bmp2b
overexpression, the offspring of Tg(hsp70l:bmp2b)fr13 transgenicThe Americanfish were subjected to a 30 min heat shock (transfer from 28C
to 39C) at 48 hpf, as described.25Results
Clinical Findings in TPBS Families
Wehave examinedfiveTPBS families presentingwith avari-
able expression of clinical symptoms (Figure 1A, B, and
Table 1). We observed mild facial dysmorphism, including
round face and craniosynostosis, mild hypertelorism, and
micrognathia, in themajority of TPBS cases (Table 1). Distal
limb anomalies affected bothhands and feet andwere char-
acterizedby short andabducted thumbs, short anddeviated
halluces, and syndactyly. Typical preaxial brachydactyly of
digits 1–3 was seen in all affected individuals and, in addi-
tion, hyper- and symphalangism, radio-ulnar synostosis,
and carpal or tarsal fusions were observed in X-rays ofJournal of Human Genetics 87, 757–767, December 10, 2010 759
Table 1. Clinical Findings in TPBS Families Carrying CHSY1 Mutations
Family Data TB-1 TB-2 TB-3 TB-4 TB-5
Consanguinity þ þ þ þ þ
Number of affected individuals 1 2 3 1 3
Mutation (nucleotide change) c.55-84del c.14delG c.205C>T c.3213C>G c.1616C>G
Mutation (protein change) G19_L28del G5AfsX30 Q69X  P539R
Origin Egypt Egypt Turkey Sri Lanka Pakistan
Facial Dysmorphism
Plagiocephaly þ þ þ/  
Hypertelorism þ þ  þ 
Micro- or retrognathia þ þ   
Dental Anomalies
Microdontia þ þ þ þ þ
Talon cusps þ þ þ þ 
Hearing Loss
Sensorineural þ þ þ þ þ
Conductive     þ
Malformed ears þ þ þ ? 
Hand or Foot Anomalies
Short fingers or toes I, II, III þ þ þ þ þ
Syndactyly þ þ þ þ þ
Abducted thumbs þ þ þ þ þ
Lateral/medial deviations of fingers/toes þ þ þ þ þ
Clinodactyly þ þ þ þ þ
Radiological Findings
Preaxial brachydactyly þ þ þ þ þ
Short metacarpals/metatarsals þ þ þ þ þ
Hyperphalangism þ þ þ þ þ
Symphalangism þ þ þ þ þ
Phalangeal duplications þ þ þ þ þ
Radioulnar synostosis    þ 
Skeletal Anomalies
Kyphoscoliosis þ þ þ/  
Pectus excavatum þ    
Generalized osteoporosis þ þ þ n.a. n.a.
Additional Findings
Developmental delay þ þ þ ? 
Mental retardation þ þ þ ? 
MRI findings n.a. partial
agenesis
of the
cerebellar
vermis
cerebellar
degeneration,
mild brain
stem atrophy
n.a. n.a.
Optic atrophy    þ 
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somecases. Further skeletal anomalies showedaprogressive
course in TPBS patients and included growth retardation,
kyphoscoliosis, and pectus excavatum. Interestingly, we
found moderate to profound sensorineural hearing loss in
almost 80% of the cases.
Mapping of the TPBS Locus and Identification
of CHSY1 Mutations
Initially, we genotyped DNA samples from available family
members of the originally described TPB1 family (4) and
one additional family, TPB2, which both originated from
Egypt, by using the AffymetrixGeneChipHumanMapping
10K SNPArray (version 2.0). Affected individuals were born
to consanguineous parents in both families. Two possibly
linked loci on chromosomes1p33and15q26wereobserved
andhad a combinedparametric LODscore of 2.37 and2.51,
respectively (Figure S1). Extensive analysis of microsatellite
markers of these regionsmapped theTPBS locus to chromo-
some 15q26-qterm between SNPs rs1480952 and rs352744
(Figure 1A; see also Figure S2), defining a shared homozy-
gous critical interval of approximately 3.8 Mb and
excluding the 1p33 region (Figure 1C; see also Figure S2).
Mapping data of one additional TPBS family, TPB3 from
Turkey, confirmed theTPBS locuswithout reducing the crit-
ical region (Figure 1A).
Among the 20 annotated genes within this region, we
sequenced four of them as highly relevant positional
candidate genes (ADAMTS17, CHSY1, PCSK6, and SELS;
Table S1). Sequencing of the three coding exons of the
chondroitin synthase 1, CHSY1, gene revealed different
homozygous mutations in affected individuals in each of
the three linked families as well as two additional families
with TPBS, which were subsequently tested. CHSY1 is tran-
scribed to a 4549 bp transcript (NM_014918.4), which
encodes a protein of 803 amino acids. All mutations cose-
gregated with the disease in the families and were not
found in more than 150 healthy control individuals. We
found three mutations in exon 1 of CHSY1: a 30 bp dele-
tion, c.55-84del (p.G19_L28 del, TPB1 family); a 1 bp dele-
tion, c.14delG (p.G5AfsX30, TPB2 family); and the
c.205C>T nonsense mutation (p.Q69X) in all three
affected individuals of the TPB3 family (Figures 1D and
1E). An acceptor splice-site mutation, c.321-3C>G, was
identified in the TPB4 family, whereas the only missense
mutation, c.1616C>G (p.P539R, TPB5 family), was located
in exon 3 of the gene (Figures 1D and 1E).
The acceptor splice-site mutation c.3213C>G is pre-
dicted to cause skipping of CHSY1 exon 2 and lead to the
loss of 496 bp on the transcript level and thus a frame shift
and premature protein truncation. We confirmed skipping
of exon 2 on cDNA of the affected individual (Figures S2A
and S2B). The only missense mutation identified, p.P539R,
affects a highly conserved proline (Figure 2C).
Expression of chsy1 in Zebrafish
No Chsy1 knockout mice have been reported yet. However,
consistent with the phenotypic traits of TPBS, our in situThe Americanhybridization analysis revealed Chsy1 expression in chon-
drocytes and the developing inner ear of E12.5 and E14.5
mouse embryos (data not shown). To address the develop-
mental functions of CHSY1 and CS, and their possible rela-
tionship to BMP signaling, we turned to the zebrafish
system. Whole-mount in situ hybridization revealed wide-
spread expression of chsy1 in the head (data not shown)
and prominent expression in the floor plate (Figure 3A)
and the fin epithelium (Figures 3B and 3D) of wild-type ze-
brafish embryos at 24 hr postfertilization (hpf). During the
second day of development, prominent expression was
also detected in the heart (data not shown), chondrocytes
of the developing head skeleton (Figure 3E), pharyngeal
endoderm of the branchial arches (Figure 3F,G), distal
regions of the pectoral fin buds (Figure 3H), and epithelial
protrusions of the inner ears (Figure 3I). These protrusions
later fuse to form the semicircular canal ducts; the central
components of the vestibular system contribute to angular
motion sensing and body balancing.26 After this fusion has
occurred, chsy1 transcript levels appear to drop (Figure 3J).
Phenotypes of Zebrafish after Loss and Gain of chsy1
Activity and the Correlation of chsy1 to bmp2b
and dan
To knock down Chsy1 activity, we injected zebrafish
embryos with antisense morpholino oligonucleotides
(MOs; for efficacy control; see Figure S3). In addition, for
gain-of-function studies, we injected in vitro synthesized
human CHSY1mRNA. Surprisingly, both treatments led to
similar defects, including a significant reduction of body
length (Figures 4A–4C), compromised pectoral fin forma-
tion (Figures4D–4F), severemidlinedeficiencies in thecarti-
lage of the neurocranium (Figures 4G and 4H), notochord
undulation (Figures 4Kand4L), and later, notochorddegen-
eration (Figures 4I and 4J), which could be correlated with
the aforementioned chsy1 expression in the overlying floor-
plate cells (see above; Figure 3A) and with the shorter body
length (Figure4B). Furthermore, chsy1morphantsdisplayed
reduced eye distances, as well as slight cyclopia in severe
cases (Figures 4M–4O), which is linked with the neurocra-
nial deficiencies (Figures 4G and 4H). In addition, the eyes
developed colobomas (Figures 4P–4R).
In the inner ears, formation of epithelial protrusions and
semicircular canals was severely compromised (Figures 5A–
5D). However, according to msxc in situ hybridization
and FITC-phalloidin staining of hair cells, the cristae and
maculae, semicircular canal- and otolith-associated sen-
sory patches of the ear, respectively, did not show major
alterations in chsy1 morphants (Figures 5K–5N). This
suggests that, rather than being important for hair cell
development itself, Chsy1 might be instrumental for
proper morphogenesis of the vestibular organ.
Positive and negative effects on semicircular canal
development have also been reported for BMP signaling.
Although according to genetic analysis, late loss of
Bmp2b function leads to defective semicircular canal mor-
phogenesis,27 another report describes similar effectsJournal of Human Genetics 87, 757–767, December 10, 2010 761
Figure 2. Additional Molecular Findings in TPBS
(A) Amplification of CHSY1 cDNAs of the TPB4 patient carrying the c.3213C>G splice-site mutation and of a healthy control. The
forward primer was located in exon 1, and the reverse primer was located in exon 3. Complete loss of the normal amplicon size in
the patient’s cDNA was due to the skipping of exon 2. Abbreviations are as follows: M, marker; WT, wild-type control; and C, water
control without DNA.
(B) Electropherograms of CHSY1 transcripts from the wild-type control and patient TPB4 show the skipping of exon 2 in the patient.
(C) An amino acid sequence alignment of CHSY1 proteins of different species shows the highly conserved proline at position 539.
(D) A PCR and enzyme-digestion method was used as a second independent method of showing the cosegregation of the c.1616C>G
(p.P539R) missense mutation in the TPB5 family. The mutation abolishes one of the two Bsl I restriction sites in the amplicon. Parents
were heterozygotes, and all three patients (II3, II5 and II6) were homozygotes for the mutation, whereas none of the three healthy
siblings had the homozygous mutation. Abbreviations are as follows: M, Marker; C, healthy control individual; and UF, undigested
PCR fragment.under Bmp2b/4 gain-of-function conditions.28 bmp2b and
chsy1 are expressed in a largely complementary manner.
At 56 hpf, bmp2b expression is strongest in the developing
cristae of the inner ear (Figure 5J), where chsy1 expression
is very weak (Figure 5G). In contrast, the epithelial protru-
sions display strong expression of chsy1 (Figure 5G) and
the Bmp inhibitor dan24 but weak bmp2b expression (Fig-
ure 5J). Consistently, transgenic overexpression of bmp2b
during the second day of development or MO-mediated
knockdown of dan led to impaired semicircular-canal for-
mation similar to that caused by knockdown of chsy1
(Figures 5E and 5F). Furthermore, both treatments compro-
mised chsy1 expression in the epithelial protrusions
(Figures 5H and 5I). Together, this suggests that Bmp
signaling has a negative effect on chsy1 expression and
that Dan is required for inhibition of Bmp signaling and
derepression of chsy1 expression in epithelial protrusions;
Dan thereby allows semicircular canal morphogenesis.762 The American Journal of Human Genetics 87, 757–767, DecembIt is tempting to speculate that Bmp inhibition and
Chsy1 play a similar role during morphogenesis of the
cochlea, the central auditory structure in mammals, and
that they possibly underlie the hearing loss in human
TPBS patients.Discussion
In the present study we showed that congenital bilateral,
symmetric preaxial brachydactyly and hyperphalangism
of digits, facial dysmorphism, dental anomalies, sensori-
neural hearing loss, and growth retardation in the Temt-
amy preaxial brachydactyly syndrome (TPBS) are caused
by recessive mutations in CHSY1. The encoded protein,
chondroitin synthase 1, is a key protein in the biosynthesis
of chondroitin sulfate (CS). It belongs to the glycosamino-
glycans (GAGs) and is composed of alternating glucuronicer 10, 2010
Figure 3. Expression of chsy1 during Zebrafish Development
Ages of embryos and larvae (in hpf) are indicated in the lower right corners, and the in situ hybridization probes (A–F and H–J) or anti-
body (G) are indicated in the lower left corners. (A–C, F–J) Lateral views. Anterior is to the left. (D) A transverse section through the tail.
Dorsal is to the top. (E) A ventral view of the head region.
(A–F and H–J) Whole-mount in situ hybridization with a chsy1 antisense probe to detect chsy1mRNA (A, B, D, E, F, H, I, and J), sox9a
antisense probe19 to colabel chondrocytes (E, in red), and a chsy1 sense control probe (C). (G) Whole-mount anti-Zn5 immunostaining,
marking the pharyngeal endoderm (compare with Piotrowski and Nu¨sslein-Volhard 40). chsy1 is expressed in the floor plate (fp), located
between the spinal cord and the notochord (nc) (A), in the basal keratinocyte layer of the fin epithelium (B and D), in somatic cells close
to the myosepta (B), in chondrocytes of the neurocranium and pharyngeal arches of the visceral skeleton (E), in the pharyngeal endo-
derm (pe) of the branchial arches (F), and in epithelial protrusions of forming semicircular canals in the inner ear (I). When these epithe-
lial protrusions have fused in the center of the otic vesicle, chsy1 transcript levels drop (J).
Abbreviations are as follows: ep, epithelial protrusions; et, ethmoid plate (neurocranium); fep, fin epithelium; fp, floor plate; hy, hyoid
(second pharyngeal arch); md, mandibular (first pharyngeal arch); nc, notochord; pe, pharyngeal endoderm; pfb, pectoral fin bud; s,
somite; and tc, trabeluca cranii (neurocranium).acid (GlcUA) and N-acetyl galactosamine (GalNAc) resi-
dues.29 CS can be synthesized in multistep processes
as covalently bound side chains of proteins known as
proteoglycans.30 CHSY1 has both the glucuronyltransfer-
ase II and N-acetylgalactosaminyl-transferase II activities
required for the synthesis of the repeating disaccharide
unit of CS. Both deletions and the p.Q69X nonsense
mutation, all located in exon 1 of CHSY1, can be expected
to cause structural alterations and disruption of the CHSY1
protein structure. We also confirmed that the acceptor
splice-site mutation c.3213C>G causes skipping of
CHSY1 exon 2 and leads to the loss of 496 bp on the
transcript level and a frame shift and premature protein
truncation. Therefore, it is likely that the c.3213C>G
mutation also leads to a nonfunctional CHSY1 protein.
We only identified one missense mutation, p.P539R,
which affects a highly conserved proline within the func-
tionally important chondroitin N-acetylgalactosaminyl-
transferase (CHGN) domain of CHSY1 (Figure 1E). TheThe Americansubstitution of proline by arginine might interfere with
the normal folding of this domain and thus prevent effi-
cient protein function. Taken together, these findings
demonstrate that complete or nearby complete loss of
CHSY1 function underlies autosomal-recessive TPBS.
Our zebrafish study demonstrated that both loss and
gain of Chsy1 function lead to similar defects during
various morphogenetic processes in the zebrafish; some
of these processes might be equivalent to the distal limb
malformations, craniofacial dysmorphism, shorter stature,
and hearing loss caused by the homozygous loss of human
CHSY1 function in TPBS. The similarity of the zebrafish
inner-ear phenotype after loss and gain of Chsy1 or Bmp
activity, together with the loss of chsy1 transcription after
gain of Bmp signaling, further suggests that a similar dereg-
ulation of CHSY1 might at least partly underlie the
different defects caused by aberrant BMP signaling in
mammals. Such defects include craniofacial and inner-
ear dysmorphologies31–33 and the different types ofJournal of Human Genetics 87, 757–767, December 10, 2010 763
Figure 4. Phenotypes of Zebrafish Larvae after Loss and Gain of chsy1 Function
Ages of zebrafish larvae (in hpf) are indicated in the lower right corners, and treatments are indicated in the upper right corners. Abbre-
viations are as follows: MO, embryo injected with antisense morpholino, loss of function; RNA, embryo injected with synthetic mRNA,
gain of function; and wt, unjected wild-type control.
(A–C) Lateral views of live animals, displaying reduced body length and altered head morphology after chsy1 loss and gain of function.
(D–F) Dorsal views of the anterior trunk of live larvae, displaying pectoral fins with variably reduced outgrowth. Upper fin in (F) is of
normal size and shape. Compared to the other phenotypic traits, impaired fin development was only moderately penetrant (approxi-
mately 30%), and it often occurred in a unilateral manner (as in F). (G and H) Alcian blue staining of cartilage of the neurocranium.
For a better appreciation of the neurocranial deficiencies, the visceral skeleton was manually removed.
(I and J) Lateral view of the trunk of live animals, revealing degeneration of notochord cells in the morphant. In several zebrafish
mutants, notochord degeneration is linked to and most likely causative of reduced body length,41 as also seen in the chsy1 morphants
described here.
(K and L) View of the trunk of live embryo. The notochord undulation of the morphant indicates that the shortened body length cannot
be solely caused by notochord degeneration. Similar notochord undulation has been observed in several zebrafish mutants, e.g., those
carrying loss-of-function mutations in wnt5a,36 pointing to a possible additional role of Chsy1 in modulating noncanonical Wnt
signaling.
(M–O) Dorsal view of the heads of live larvae. Medial expansion of the eyes and loss of midline forebrain tissue leads to partial cyclopia.
Note that in the morphants shown here, the pectoral fins are not or only moderately affected.
(P–R) Lateral view of the eyes, revealing lack of dorsal retinal tissue and failed closure of the choroid fissure (coloboma). This phenotypic
trait is linked to the above-described medial-forebrain deficiencies and shifts of the eyes to more medial positions, and it might be
a secondary consequence of the overall alterations in head and head-skeleton morphology.
Abbreviations are as follows: cf, choroid fissure of eye; et, ethmoid plate (neurocranium); pf, pectoral fin bud; and tc, trabeluca cranii
(neurocranium).human brachydactylies, caused by either gain or loss of
BMP signaling.1 Future studies will have to reveal the
molecular mechanisms of chsy1 repression by Bmp sig-
naling and of Chsy1 and CS function. Computational764 The American Journal of Human Genetics 87, 757–767, Decembanalysis of human CHSY1 revealed the presence of several
Smad transcription-factor binding sites (data not shown),
suggesting that the effect of BMP signaling on CHSY1
expression might be direct. CS, in turn, could haveer 10, 2010
Figure 5. Interaction between chsy1, bmp2b, and dan during Inner-Ear Morphogenesis
Ages of larvae (in hpf) are indicated in lower right corners, and treatments are indicated in upper right corners. Abbreviations are as
follows: MO, embryo injected with antisense morpholino; RNA, embryo injected with synthetic mRNA; tg(bmp2b), transgenic after
heatshock induction of ubiquitous bmp2b expression;25 and wt, unjected or nontransgenic wild-type control.
(A–F) Lateral views of the inner ear of live animals. In the wild-type control (A), the walls of the semicircular canals are outlined by dots.
(G–H) Inner ears after whole-mount in situ hybridization for chsy1 (t-v) or bmp2b (w) mRNA. For details, see text.
(G–L) Lateral views of the inner ears after whole-mount in situ hybridization for chsy1 (G–I), bmp2b (J), or msxc (K and L). (G–I) chsy1
mRNA levels in epithelial protrusions (ep) are strongly reduced after overexpression of bmp2b (H) and after inactivation of the BMP
inhibitor Dan (I). The much weaker expression in the cristae primordia (cr) remains unaltered (compare G and H). (J) In contrast to
chsy1 (see G), bmp2b is strongly expressed in the cristae of the wild-type inner ear (K and L).msxc expression in cristae of the chsy1mor-
phant is unaltered (L). Becausemsx genes are known transcriptional targets of BMP signaling, these data also suggest that, in contrast to
the BMPs upstream of chsy1, Chsy1 does not act upstream of BMP signaling.
(M and N)Merged stacks of confocal images of inner ears after fluorescein (FITC)-phalloidin staining. Cristae (indicated by white arrows)
of wild-type and morphant larvae contain hair cells of indistinguishable numbers and morphology.
Abbreviations are as follows: cr, crista (sensory patch of inner ear); ep, epithelial protrusions; o, otolith; and pc, posterior semicircular
canal.a structural role during morphogenetic processes, consis-
tent with its expression in the tips of the epithelial pro-
jections of the forming semicircular canals and with the
described role of other GAGs such as hyaluronic acid
during zebrafish inner-ear morphogenesis.34 In addition,
as a component of proteoglycans-like aggrecan or versican,
CS might feed back to BMP or other growth-factor sig-
naling, consistent with the described activities of proteo-
glycans as growth-factor binding proteins and/or corecep-
tors.35 For instance, an undulated notochord phenotype as
in zebrafish chsy1 morphants is also displayed by wnt5a
mutants,36 pointing to a possible involvement of CHSY1
in noncanonicalWNTsignaling. Furthermore, as described
in detail in the accompanying work by Tian et al.,37 CHSY1
could modulate signaling through the Notch receptor.
CHSY1 has a Fringe domain, which is possibly involved
in glycosylation of Notch receptors and thus modifying
their ligand specificity and signaling efficiency.38 Consis-
tent with a role of Chsy1 in reducing Notch signal-
ing, we found that conditional expression of the constitu-
tively active intracellular domain of Notch in zebrafish
causes compromised semicircular-canal formation, asThe Americandoes loss of Chsy1 activity (K.L. and M.H., unpublished
data). Together, the negative role of Bmp signaling
on chsy1 expression and the negative role of Chsy1 on
Notch signaling are in line with the synergistic effect of
Notch function downstream of Bmp signaling as reported
in many different developmental and physiological
scenarios.39
In conclusion, we show that loss of human CHSY1 func-
tion causes autosomal-recessive Temtamy preaxial brachy-
dactyly syndrome and that antisense-mediated chsy1
knockdown in zebrafish causes similar defects in multiple
developmental processes. In the inner ears of zebrafish
larvae, unrestricted Bmp2b signaling or loss of Dan activity
leads to reduced chsy1 expression and, during epithelial
morphogenesis, defects similar to those that occur upon
Chsy1 inactivation, indicating that Bmp signaling affects
inner-ear development by suppressing Chsy1.Supplemental Data
Supplemental Data include three figures and two tables and are
available with this article online at http://www.cell.com/AJHG/.Journal of Human Genetics 87, 757–767, December 10, 2010 765
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